Primary malignancy | No. | Survival period (months) | Tokuhashi score | Tomita score | Prognosis | |||
---|---|---|---|---|---|---|---|---|
Mean (95% CI) | Median (95% CI) | Original | Adjusted | Original | Adjusted | |||
Lymphoma | 3 | 53.9 (20.1 - 87.8) | - | - | 5 | - | 1 | Favor |
MM* | 5 | 46.5 (33.8 - 59.2) | - | - | 5 | - | 1 | |
Thyroid | 2 | 45.9 (5.9 - 85.9) | 17.1 | 5 | 5 | 1 | 1 | |
Breast | 5 | 31.4 (15.4 - 47.4) | - | 5 | 5 | 1 | 1 | |
Uterus | 4 | 14.4 (0.0 - 29.5) | 3.9 (0.0 - 12.9) | 3 | 4 | 2 | 2 | Intermediate |
Liver | 19 | 12.2 (6.6 - 17.7) | 8.5 (5.6 - 11.5) | 1 | 4 | 4 | 2 | |
Prostate | 6 | 10.9 (1.6 - 20.2) | 5.1 (4.1 - 6.0) | 5 | 3 | 1 | 2 | |
Kidney | 7 | 10.8 (5.9 - 15.7) | 9.2 (5.2 - 13.3) | 3 | 3 | 2 | 2 | |
Lung | 23 | 6.0 (3.7 - 8.3) | 4.3 (1.3 - 7.3) | 0 | 1 | 4 | 4 | Poor |
Esophagus | 3 | 6.0 (0.0 - 13.4) | 2.3 (2.0 - 2.6) | 0 | 1 | - | 4 | |
Colon | 5 | 6.0 (3.8 - 8.2) | 4.7 (4.5 - 4.9) | 2 | 1 | 4 | 4 | |
Stomach | 4 | 5.5 (2.0 - 8.9) | 3.4 (0.8 - 5.9) | 0 | 0 | - | 4 | |
GB/Biliary | 3 | 3.5 (0.7 - 6.3) | 4.5 (0.0 - 10.7) | 1 | 0 | - | 4 | |
Rectum | 9 | 3.1 (2.1 - 4.0) | 3.3 (2.4 - 4.3) | 4 | 0 | - | 4 | |
Bladder | 1 | 2.7 | 2.7 | 0 | 0 | - | 4 | |
Others* | 13 | 18.9 (7.3 - 30.4) | 6.3 (0.0 - 14.3) | 2 | 2 | - | 2 | Intermediate |
Overall | 112 | 17.3 (12.6 - 22.1) | 5.8 (5.0 - 6.7) |